Cytek Biosciences (CTKB) Depreciation and Depletion (2020 - 2026)

Cytek Biosciences' Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• Quarterly Depreciation and Depletion rose 11.11% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 11.11% YoY) and the FY2025 annual result came in at $3.9 million, up 11.43% from the prior year.
• Depreciation and Depletion was $1.0 million for Q1 2026 at Cytek Biosciences, roughly flat from $1.0 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $1.0 million in Q2 2025 and bottomed at $300000.0 in Q1 2022.
• A 5-year average of $752941.2 and a median of $900000.0 in 2023 frame the typical range for Depreciation and Depletion.
• Annual changes were most pronounced in 2023 — Depreciation and Depletion soared 125.0% — and 2024, when it changed 0.0%.
• Cytek Biosciences' Depreciation and Depletion stood at $500000.0 in 2022, then surged by 60.0% to $800000.0 in 2023, then gained by 12.5% to $900000.0 in 2024, then advanced by 11.11% to $1.0 million in 2025, then changed by 0.0% to $1.0 million in 2026.
• Business Quant data shows CTKB's Depreciation and Depletion at $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $1.0 million in Q3 2025.